Ardelyx (ARDX) Other Non-Current Assets (2013 - 2026)

Ardelyx (ARDX) posted Other Non-Current Assets of $6.7 million for Q1 2026, down 3.63% on a QoQ basis from $6.9 million in Q4 2025, and down 2.02% year-over-year from $6.8 million in Q1 2025.

Ardelyx (ARDX) Other Non-Current Assets (2013 - 2026) Analysis & Trends

Ardelyx's Other Non-Current Assets history runs 14 years deep, the most recent figure standing at $6.7 million for Q1 2026.

  • Quarterly Other Non-Current Assets fell 2.02% year-over-year to $6.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (down 2.02% YoY) and the FY2025 annual result came in at $6.9 million, up 28.06% from the prior year.
  • Other Non-Current Assets was $6.7 million for Q1 2026 at Ardelyx, down from $6.9 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $13.3 million in Q3 2022 and bottomed at $673000.0 in Q2 2023.
  • A 5-year average of $4.9 million and a median of $5.4 million in 2024 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 976.01% — and 2023, when it tumbled 88.36%.
  • Ardelyx's Other Non-Current Assets stood at $881000.0 in 2022, then soared by 308.17% to $3.6 million in 2023, then soared by 50.61% to $5.4 million in 2024, then advanced by 28.06% to $6.9 million in 2025, then slipped by 3.63% to $6.7 million in 2026.
  • Business Quant data shows ARDX's Other Non-Current Assets at $6.7 million in Q1 2026, $6.9 million in Q4 2025, and $6.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Ardelyx 1.26 Bn 1.02 Bn 89.66 Mn 6.68 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.68 Mn
Dec 31, 2025 6.94 Mn
Sep 30, 2025 6.78 Mn
Jun 30, 2025 7.07 Mn
Mar 31, 2025 6.82 Mn
Dec 31, 2024 5.42 Mn
Sep 30, 2024 5.33 Mn
Jun 30, 2024 5.45 Mn
Mar 31, 2024 5.50 Mn
Dec 31, 2023 3.60 Mn
Sep 30, 2023 1.55 Mn
Jun 30, 2023 673,000.00
Mar 31, 2023 774,000.00
Dec 31, 2022 881,000.00
Sep 30, 2022 13.32 Mn
Jun 30, 2022 4.91 Mn
Mar 31, 2022 1.23 Mn
Dec 31, 2021 1.15 Mn
Sep 30, 2021 1.24 Mn
Jun 30, 2021 1.31 Mn